Panacea Life Sciences finishes beta testing of telemedicine and peptide platform
The Colorado-based company says it is preparing a national launch after completing the beta phase.
TR
By Tom Reyes · Markets Editor
Oct 9 18:48 ETSource: The Des Moines Register
The wire
- 01Panacea Life Sciences Holdings announced it completed beta testing and is preparing a national launch of its telemedicine and peptide offering.
- 02Another telehealth entrant into peptide distribution adds to the supply channels clinicians and pharmacists are being asked about.
- 03Only the company announcement is available; products, pricing, sourcing and launch date are not specified.
From the source
Read at desmoinesregister.comPanacea Life Sciences Holdings, Inc. Completes Beta Testing and Prepares for National Launch of Telemedicine and Peptide
